High Dose IL-2 in Combination With Anti-PD-1
Clinical trial NCT03991130 · TERMINATED
Trial details
- NCT number
- NCT03991130
- Sponsor
- Gregory Daniels
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2023-02-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.